GET DAILY SIGNALSAehr Test Systems (AEHR) Reports +200% Revenue Growth in Strong Q1
Key Takeaways
- Record revenue of $33.0 million, up 200% year over year and 75% sequentially.
- GAAP net income of $7.2 million, or $0.21 per diluted share, versus a loss a year ago.
- Non-GAAP net income of $9.4 million, or $0.28 per diluted share, beating the consensus estimate of roughly $0.10–$0.11.
- Bookings of $46.7 million, a book-to-bill ratio of about 1.4, and effective backlog of $109.3 million.
- Management raised full-year fiscal 2027 revenue guidance to $150 million, with non-GAAP net income expected to be at least 20% of revenue.
Understanding the Results and Their Significance
Aehr Test Systems provides test and burn-in equipment for semiconductors used in artificial intelligence, silicon photonics, and power applications. These results offer a timely indicator of spending patterns among AI chipmakers and hyperscale data-center operators. Following a softer fiscal 2026, the focus has been on whether wafer-level and package-level burn-in demand would move into higher production volumes. This quarter provided that evidence, with revenue tripling from the year-ago period and new orders continuing to exceed shipments.
Breaking Down the Quarter's Performance
Aehr Test Systems posted record revenue of $33.0 million for the first quarter of fiscal 2027, ended September 25, 2026. This marked a 200% increase from $11.0 million in the prior-year quarter and a 75% sequential rise. GAAP gross margin reached 47.5%, while the non-GAAP figure was 48.5%.
GAAP net income came in at $7.2 million, or $0.21 per diluted share, compared with a GAAP net loss of $2.1 million, or $0.07 per diluted share, a year earlier. Non-GAAP net income, which excludes stock-based compensation and acquisition-related items, was $9.4 million, or $0.28 per diluted share, versus $0.2 million, or $0.01 per diluted share, in the same period last year. Both revenue and earnings per share exceeded Wall Street expectations.
Bookings totaled $46.7 million, surpassing revenue by more than 40% and yielding a book-to-bill ratio of approximately 1.4. Backlog stood at $100.9 million as of September 25, 2026, with effective backlog reaching $109.3 million as of November 1, 2026. Cash, cash equivalents, and restricted cash totaled $105.1 million at quarter end.
Management lifted its outlook, now projecting fiscal 2027 revenue of $150 million, up from the prior range of $130 million to $150 million, alongside non-GAAP net income of at least 20% of revenue.
I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
How the Market Responded
Shares of Aehr Test Systems rose roughly 15% in extended trading after the release, reflecting investor optimism around the revenue beat and the raised guidance. Attention centered on accelerating demand for AI semiconductor test and burn-in solutions, together with a book-to-bill ratio above 1.0 that points to ongoing order momentum. The shift to profitability after a loss-making year further supported views that operating leverage is taking hold as revenue expands.
What to Watch Going Forward
Investors will monitor whether Aehr Test Systems can translate its expanding backlog into shipped revenue across the balance of fiscal 2027. The updated $150 million revenue target implies a sizable ramp through the year, making delivery execution a key focus.
Several catalysts may influence the trajectory. A major AI processor supplier has committed to installing a fully configured FOX-XP wafer-level test cell at an OSAT partner in Taiwan, with high-volume production decisions anticipated within months of installation. Separately, the Sonoma package-level burn-in line is scaling, with a lead hyperscale customer qualifying a second AI processor.
Additional areas to track include gross margin trends, cash flow conversion amid inventory builds for shipments, and the pace of new customer evaluations across AI processors, silicon photonics, and power semiconductors. Supply-chain and customer concentration factors also warrant attention given the company’s reliance on a relatively small number of large production customers.
Using AI Tools for Deeper Analysis
One tool I find helpful for this kind of analysis is Tickeron’s AI Screener. It allows quick filtering across technical patterns, fundamentals, and AI-driven signals to surface comparable ideas or confirm relative strength without manual effort.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
AEHR sees its Stochastic Oscillator recovers from oversold territory
On October 28, 2026, the Stochastic Oscillator for AEHR moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 56 instances where the indicator left the oversold zone. In 51 of the 56 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Oscillator exited the oversold zone, 27 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
Following a +14.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 245 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
AEHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In 75 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for AEHR turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 34 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
AEHR moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AEHR crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for AEHR entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.658) is normal, around the industry mean (6.452). P/E Ratio (-223.783) is within average values for comparable stocks, (89.445). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. AEHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment
Advertisement